Progressing polypills beyond concepts to outcomes

Affiliations

¹ The George Institute for Global Health, University of New South Wales, Sydney, NSW 2042, Australia; Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Electronic address: apatel@georgeinstitute.org.
² Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Comment

Anushka A Patel et al. Lancet. 2019.

. 2019 Aug 24;394(10199):617-619.

doi: 10.1016/S0140-6736(19)31953-1.

¹ The George Institute for Global Health, University of New South Wales, Sydney, NSW 2042, Australia; Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Electronic address: apatel@georgeinstitute.org.
² Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

No abstract available

Comment on

Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial.
Roshandel G, Khoshnia M, Poustchi H, Hemming K, Kamangar F, Gharavi A, Ostovaneh MR, Nateghi A, Majed M, Navabakhsh B, Merat S, Pourshams A, Nalini M, Malekzadeh F, Sadeghi M, Mohammadifard N, Sarrafzadegan N, Naemi-Tabiei M, Fazel A, Brennan P, Etemadi A, Boffetta P, Thomas N, Marshall T, Cheng KK, Malekzadeh R. Roshandel G, et al. Lancet. 2019 Aug 24;394(10199):672-683. doi: 10.1016/S0140-6736(19)31791-X. Lancet. 2019. PMID: 31448738 Clinical Trial.